Court Sets Fall Trial Date for Shire, Barr Patent Trial Over Adderall XR

Drug Industry Daily
KEYWORDS courts / Lawsuit
A A

A U.S. federal judge has set an Oct. 30 trial date for Shire’s patent suit against Barr Laboratories over Shire’s attention-deficit/hyperactivity disorder drug Adderall XR.

To View This Article:

Login

Subscribe To Drug Industry Daily